3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels.

Daly AC, Davidson MD, Burdick JA. · 2021

Read 3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels. by Daly AC, Davidson MD, Burdick JA. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7854667.txt.

Introduction

Daly and co-authors build dense tissue models by printing cell balls into self-healing gels. Lab tissue models help study development and disease. They also screen drugs for effect and harm. Most models lack real tissue density and cell mix.

Their printer places tiny cell spheroids at fine detail. The gel support closes around each ball. Balls then fuse into one tissue with a set layout. The team printed heart tissue from stem cells. Heart muscle and fibroblast shares were set by design. The model copied scarred heart traits, with weak, uneven beating. Gene-silencing drugs were then tested for repair. The method suits many precision disease models.

Catalog record

CREATORDaly AC, Davidson MD, Burdick JA.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE76 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7854667

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels By Andrew C. Daly, Matthew D. Davidson, Jason A. Burdick Published in: Nature Communications DOI: 10.1038/s41467-021-21029-2 ABSTRACT Cellular models are needed to study human development and disease in vitro, and to screen drugs for toxicity and efficacy. Current approaches are limited in the engineering of functional tissue models with requisite cell densities and heterogeneity to appropriately model cell and tissue behaviors. Here, we develop a bioprinting approach to transfer spheroids into self-healing support hydrogels at high resolution, which enables their patterning and fusion into high-cell density microtissues of prescribed spatial organization. As an example application, we bioprint induced pluripotent stem cell-derived cardiac microtissue models with spatially controlled cardiomyocyte and fibroblast cell ratios to replicate the structural and functional features of scarred cardiac tissue that arise following myocardial infarction, including reduced contractility and irregular electrical activity. The bioprinted in vitro model is combined with functional readouts to probe how various pro-regenerative microRNA treatment regimes influence tissue regeneration and recovery of function as a result of cardiomyocyte proliferation. This method is useful for a range of biomedical applications, including the development of precision models to mimic diseases and the screening of drugs, particularly where high cell densities and heterogeneity are important. INTRODUCTION Cells possess the remarkable capacity to self-organize into multicellular spheroids in vitro, including from stem cells and into specialized organoid structures1. These spheroids are being used to emulate organs such as the intestine2, liver3, kidney4, brain5, and heart6 to study human development and disease in vitro. In these formats they are promising as drug screening platforms due to their superior predictability and physiological structure and function when compared to traditional monolayer cultures7–10. Indeed, the organotypic cell densities in spheroids enhance the cell-cell and cell-extracellular matrix (ECM) interactions that are required to maintain cellular differentiation and phenotype, whereas these interactions are limited in traditional 2D cultures11–14. High cell densities are necessary to accurately recapitulate many pathological disease states such as cancer or fibrosis where perturbed cell-cell and cell-ECM interactions are central to disease progression. For example, spheroid cultures have enabled the engineering of heart, liver, and lung fibrosis models6,15–18, and high cell densities within spheroids result in oxygen gradients that mimic the cancer microenvironment19–21. While spheroid cultures hold tremendous potential due to their organotypic cellular densities, it is difficult to control their patterning across larger length scales, to introduce the heterogeneity and resulting function of many tissues. This limits their utility as in vitro models where patterns of cells and ECM are key aspects of development or the progression of disease. For example, during fibrosis of the heart, liver and lung22,23, non-functional fibrotic tissue persists within healthy parenchyma, promoting further scarring and eventual organ failure. The development of biofabrication tools to control spheroid assembly across larger length scales through directed placement and fusion could improve their physiological relevance for a range of biomedical applications. Biofabrication technologies, such as bioprinting, enable programmed assembly of cells into complex 3D geometries24,25. However, these technologies have been predominantly designed to process cells embedded within hydrogels, which limits cell-cell interactions and results in low cell density constructs. This has motivated the development of biofabrication technologies tailored specifically for spheroids, often termed bioassembly, which leverages the capacity of spheroids to fuse through liquid-like coalescence to minimize adhesive-free energy at the interface26–28. In an early approach, extrusion bioprinting was adopted to allow spheroids to fuse together into larger tissue strands, which could then be extruded through a microcapillary29. More recent bioassembly advances enable the direct processing of single spheroids, offering improved control over spheroid patterning and overall geometries. For example, spheroids can be aspirated and then skewered onto supporting metallic needles (i.e., kenzan method) for fusion30. Hydrogels have also been used to support aspiration based methods, through the sequential layering of an uncrosslinked hydrogel precursor and spheroids, followed by hydrogel crosslinking31. A number of hydrogels have been implemented with this method including an alginate precursor solidified by ionic crosslinking with CaCl2 (delivered with a secondary humidifier step), a fibrinogen precursor solidified by enzymatic crosslinking with thrombin (delivered using secondary microvalve based deposition), and a gelatin methacryloyl precursor solidified by radical photocrosslinking with UV light. Despite advances with these bioassembly technologies, significant challenges remain, particularly to support the patterning of complex 3D structures without the need to disrupt spheroids mechanically or to use external stimuli to initiate hydrogel crosslinking. Thus, the development of improved and simplified platforms to pattern spheroids in 3D are needed. Here, we report a method where spheroids can be translated through a shear-thinning hydrogel that self-heals to receive and hold the spheroid in 3D space, including for the directed fusion between spheroids to form high cell density microtissues with defined shapes that can then be removed from the hydrogel. The self-healing properties of the support hydrogel enable precise positioning of spheroids (up to 10% of spheroid diameter) and high spheroid viability post-printing (~95%), while the viscoelastic and non-adhesive nature of the self-healing hydrogel facilitates controlled fusion between adjacent spheroids into prescribed and stable structures during culture. To demonstrate the utility of this bioprinting method, we develop a cardiac disease model that mimics post-myocardial infarction (MI) scarring, by bioprinting microtissues containing spatially controlled densities of induced pluripotent stem cell (iPSC)-derived cardiomyocytes and primary human cardiac fibroblasts (CF). The bioprinted model replicates cardiac pathologies that arise post-MI (reduced contractile output and electrical synchronization) and we use the model to probe miRNA therapeutics that improve cardiac regeneration and function as a result of cardiomyocyte proliferation. RESULTS AND DISCUSSION 3D bioprinting spheroids within self-healing hydrogels To enable the controlled patterning of spheroids, we developed a method for the bioprinting of spheroids within self-healing support hydrogels, which involves: (i) vacuum aspiration of a spheroid in a media reservoir, (ii) direct transfer of the spheroid into a support hydrogel due to its shear-thinning properties, and (iii) deposition of the spheroid at any location in the hydrogel with vacuum removal and self-healing of the hydrogel (Fig. 1a i–iii, Supplementary Movie 1). This process is enabled by the separation of the media reservoir containing the spheroids from a second reservoir containing the support hydrogel by a narrow channel for spheroid transport between the two reservoirs (Supplementary Fig. 1, Supplementary Movie 1). This approach avoids surface tension effects that can significantly reduce cell viability when transferring cells and spheroids between liquid and air interfaces31. The support hydrogel used is based on the assembly of hyaluronic acid (HA) modified with either adamantane (Ad) or β-cyclodextrin (CD) (Supplementary Fig. 2), resulting in shear-thinning and self-healing properties, as represented by a reduction in hydrogel viscosity with increasing shear rate and a recovery of storage modulus during cycles of high to low strain (Fig. 1b). This supramolecular hydrogel was developed previously for applications in the delivery of therapeutics to tissues and as a bioink for extrusion printing32–34.Fig. 13D bioprinting spheroids in self-healing support hydrogels.a Schematic (top), brightfield images (middle), and fluorescent images (bottom) demonstrating, (i) MSC spheroid aspiration in a media reservoir, (ii) spheroid transfer into a self-healing support hydrogel (FITC-labeled), and (iii) spheroid deposition within the support hydrogel through removal of vacuum from the micropipette tip. Images are representative of n = 4

Read the complete text